Skip to content

DERMAX: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

DERMAX

BE 0667.730.677
NACE 46.460, Wholesale of pharmaceutical and medical goods
NACE division 46, Wholesale trade all sizesfiscal years 2021 to 20252,802 to 24,123 sector peers per ratio

Summary

fiscal year 2025

DERMAX does better than half of its sector on 10 of the 11 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Net marginbetter than 95%
  • EBITDA marginbetter than 95%
  • Solvencybetter than 93%
Points to watch
  • Days sales outstandingbetter than 5%

Solvency and debt

How soundly the company is financed.
Solvency
92.8%▲2025

Solvency is above 93% of 24,039 sector peers: in the most favourable quarter.

Position against the sector improving since 2021.

20212022202320242025
Debt to equity
0.08▼2025

Debt to equity is below 81% of 23,857 sector peers: in the most favourable quarter.

Position against the sector improving since 2021.

20212022202320242025
Interest coverage
21.23▲2025

Interest coverage is above 67% of 20,995 sector peers: more favourable than the median.

Position against the sector stable since 2021.

20212022202320242025

Liquidity

Whether it can pay its short-term bills.
Current ratio
7.28▲2025

The current ratio is above 88% of 23,820 sector peers: in the most favourable quarter.

Position against the sector improving since 2021.

20212022202320242025
Working-capital ratio
45.4%▲2025

The working-capital ratio is above 63% of 24,002 sector peers: more favourable than the median.

Position against the sector improving since 2021.

20212022202320242025

Profitability

What the company earns on its assets and its sales.
Return on equity
9.7%▲2025

Return on equity is around the median of 20,915 sector peers.

Position against the sector improving since 2021.

20212022202320242025
Return on assets
9.0%▲2025

Return on assets is above 70% of 24,123 sector peers: more favourable than the median.

Position against the sector improving since 2021.

20212022202320242025
Net margin
33.3%2025

The net margin is above 95% of 3,075 sector peers: in the most favourable quarter.

20212022202320242025
EBITDA margin
77.3%2025

The EBITDA margin is above 95% of 2,802 sector peers: in the most favourable quarter.

20212022202320242025
Gross margin
47.5%2025

The gross margin is above 86% of 2,983 sector peers: in the most favourable quarter.

20212022202320242025

Working-capital cycle

How long cash is tied up in customers, suppliers and stock.
Days sales outstanding
347days2025

Days sales outstanding is above 95% of 3,038 sector peers: in the least favourable quarter.

20212022202320242025
Days payable outstanding
185days▼2025

Days payable outstanding is above 91% of 3,077 sector peers.

20212022202320242025

Not computable

Long-term debt ratio, Days inventory. The filed figures do not contain the lines these need.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.